Oral immunotherapy for cow’s milk allergy appears to effectively desensitise allergic children, a new study indicates, although further work is needed to determine the best dosing, duration of therapy, and whether permanent tolerance can be achieved, the study team emphasises.

Twenty children, six to 17 years of age, with a known history of milk allergy were randomly assigned to placebo or to milk in a three-phase dosing schedule. On the first day, a dose of 0.4mg milk protein was administered, and escalated about every 30 minutes to a maximum first-day dose of 50mg.

Home dosing was then initiated at the highest tolerated dosage, followed by eight weekly in-office dose increases to a maximum of 500 mg. Once a dose of 500mg (equivalent to 15ml of milk) was achieved, participants remained on this daily maintenance dose for 13 weeks.

Twelve children in the active group and seven in the placebo group completed the study, Dr Robert A. Wood from the Johns Hopkins Hospital, Baltimore, and colleagues report in the Journal of Allergy and Clinical Immunology.

One child dropped out due to persistent eczema during dose escalation. “Adverse reactions were common, but the risk of a severe reaction fell within the range that we would consider acceptable. Despite the relatively high frequency of reactions of any type (45 per cent of active doses), nearly 90 percent were transient reactions that required no treatment.”

The researchers found that milk oral immunotherapy was effective in increasing the threshold for reactions to milk in all treated children. Before treatment, nearly all of the children had symptoms after exposure to an average of 40mg of milk. Following milk oral immunotherapy, the children had an allergic reaction only after exposure to an average of 5,140mg milk. There were changes in the placebo group.

After milk immunotherapy, the lowest milk dose to cause a reaction was 1,340mg, “which is still likely to be protective against the overwhelming majority of accidental exposures,” the investigators note.

However, despite an increased reaction threshold after completion of the oral milk immunotherapy regimen, post-treatment food challenge still elicited reactions in 14 of 18 children, Dr Wood and colleagues point out.

Even in those who did not react to the post-treatment food challenge, “it is not clear whether they are fully tolerant or rather transiently desensitised and thus still at risk of future reactions,” the researchers added.

Reuters Health

Source: Journal of Allergy and Clinical Immunology, December 2008.

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.